

Author: Marinaro M. Boyaka P.N. Kiyono H. McGhee J.R.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.7, Iss.10, 1998-10, pp. : 1657-1666
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Modulation of Th1 and Th2 responses for immunotherapy
Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 3, 2002-03 ,pp. :


Regulation of Angiogenesis by Th1- and Th2-Type Cytokines
Current Pharmaceutical Design, Vol. 9, Iss. 7, 2003-03 ,pp. :


By Bhardwaj Jyoti Chaudhary Narendra Seo Hyo-Jin Kim Min-Yong Shin Tai-Sun Kim Jong-Deog
Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 3, 2014-06 ,pp. :


Antioxidants Suppress Th1-Type Immune Response In Vitro
Drug Metabolism Letters, Vol. 1, Iss. 3, 2007-08 ,pp. :